Authors
Loading...
Network meta-analysis compares tirzepatide and semaglutide for weight reduction in non-diabetic adults, indicating varying doses influence outcomes.
Kasagga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: